Massis L M, Braga C J M, Sbrogio-Almeida M E, Lauand C, Newton S M C, Klebba P E, Ferreira L C S
Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, SP, Brasil.
Mem Inst Oswaldo Cruz. 2008 Sep;103(6):606-10. doi: 10.1590/s0074-02762008000600017.
In the present study we investigated the flagellin-specific serum (IgG) and fecal (IgA) antibody responses elicited in BALB/c mice immunized with isogenic mutant derivatives of the attenuated Salmonella enterica serovar Typhimurium (S. Typhimurium) SL3261 strain expressing phase 1 (FliCi), phase 2 (FljB), or no endogenous flagellin. The data reported here indicate that mice orally immunized with recombinant S. Typhimurium strains do not mount significant systemic or secreted antibody responses to FliCi, FljB or heterologous B-cell epitopes genetically fused to FliCi. These findings are particularly relevant for those interested in the use of flagellins as molecular carriers of heterologous antigens vectored by attenuated S. Typhimurium strains.
在本研究中,我们调查了用表达1期鞭毛蛋白(FliCi)、2期鞭毛蛋白(FljB)或无内源性鞭毛蛋白的减毒肠炎沙门氏菌鼠伤寒血清型(鼠伤寒沙门氏菌)SL3261菌株的同基因突变衍生物免疫的BALB/c小鼠中引发的鞭毛蛋白特异性血清(IgG)和粪便(IgA)抗体反应。此处报告的数据表明,用重组鼠伤寒沙门氏菌菌株口服免疫的小鼠对FliCi、FljB或与FliCi基因融合的异源B细胞表位不会产生显著的全身或分泌性抗体反应。这些发现对于那些有兴趣将鞭毛蛋白用作减毒鼠伤寒沙门氏菌菌株携带的异源抗原分子载体的人来说尤为重要。